Showing results (1-10 of 283) with videos related to
Sort By:
Pageof 29
Cancer Treatment and Research|November 30, 2022
Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year UpdateCharles L Bennett, Bartlett Witherspoon, Kenneth R CarsonBest Practice & Research. Clinical Haematology|March 29, 2005
Clinical characteristics of erythropoietin-associated pure red cell aplasiaKenneth R Carson, Andrew M Evens, Charles L Bennett, et al.Cancer Treatment and Research|November 30, 2022
Was There Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occurring in CopenhagenCharles L Bennett, Bartlett Witherspoon, Kenneth R Carson, et al.The American Journal of Managed Care|April 11, 2024
Adjusting starting points for initial price offers: the example of ibrutinibJason B Gibbons, Charles L Bennett, Kenneth R Carson, et al.American Journal of Hematology|February 12, 2025
Ferric Carboxymaltose (FCM)-Associated Hypophosphatemia (HPP): A Systematic ReviewJoseph Magagnoli, Kevin Knopf, William J Hrushesky, et al.The Lancet. Oncology|August 4, 2009
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) ProjectKenneth R Carson, Daniele Focosi, Eugene O Major, et al.Expert Opinion on Drug Safety|September 24, 2015
Risk-adapted strategies for the treatment of Hodgkin lymphomaJesse Keller, Kenneth R CarsonExpert Opinion on Drug Safety|May 14, 2014
A drug safety evaluation of rituximab and risk of hepatitis BPeter Riedell, Kenneth R CarsonScience (New York, N.Y.)|February 12, 2005
Astrophysical observations: lensing and eclipsing Einstein's theoriesCharles L BennettPageof 29